{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T07:55:37Z","timestamp":1794124537989,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005923","name":"International Association for the Study of Lung Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtho.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T16:12:26Z","timestamp":1691597546000},"page":"1689-1702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma"],"prefix":"10.1016","volume":"18","author":[{"given":"Andrea S.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy J.","family":"Giroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy L.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie W.","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey I.","family":"Pass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2023.08.005_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","article-title":"Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients","volume":"31","author":"Butchart","year":"1976","journal-title":"Thorax"},{"key":"10.1016\/j.jtho.2023.08.005_bib2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","article-title":"A\u00a0proposed new international TNM staging system for malignant pleural mesothelioma. From the international mesothelioma interest group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2023.08.005_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.semtcvs.2009.07.002","article-title":"Recent advances in mesothelioma staging","volume":"21","author":"Richards","year":"2009","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.jtho.2016.09.121","article-title":"The IASLC Mesothelioma Staging Project: Proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"Rice","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib5","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","article-title":"The IASLC mesothelioma staging project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma","volume":"11","author":"Rusch","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib6","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jtho.2016.08.147","article-title":"The IASLC mesothelioma staging project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"Nowak","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee","volume":"9","author":"Pass","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib9","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jtho.2016.09.123","article-title":"The IASLC mesothelioma staging project: improving staging of a rare disease through international participation","volume":"11","author":"Pass","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jtho.2016.02.006","article-title":"Plasma biomarker enrichment of clinical prognostic indices in malignant pleural mesothelioma","volume":"11","author":"Pass","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib11","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III Study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jtcvs.2007.10.054","article-title":"Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. Comparative Study","volume":"135","author":"Flores","year":"2008","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.athoracsur.2014.09.056","article-title":"Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma","volume":"99","author":"Taioli","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2023.08.005_bib15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2023.08.005_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jtho.2023.08.005_bib17","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/1759-7714.13063","article-title":"Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database","volume":"10","author":"Zhuo","year":"2019","journal-title":"Thorac cancer"},{"key":"10.1016\/j.jtho.2023.08.005_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/carcin\/bgz004","article-title":"Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database","volume":"40","author":"Van Gerwen","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jtho.2023.08.005_bib19","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/cncr.24886","article-title":"Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases","volume":"116","author":"Richards","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2023.08.005_bib20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jtcvs.2008.12.045","article-title":"Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors","volume":"138","author":"Yan","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2023.08.005_bib22","first-page":"298","article-title":"Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy","volume":"40","author":"Sugarbaker","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib23","article-title":"Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors","volume":"5","author":"Kidd","year":"2018","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jtho.2023.08.005_bib24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A\u00a0novel clinical prediction model for prognosis in malignant pleural mesothelioma using Decision Tree Analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jtho.2018.10.005","article-title":"Prediction modelling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients undergoing cytoreductive surgery","volume":"14","author":"Harris","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jtho.2023.08.005_bib27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.athoracsur.2010.04.110","article-title":"Characteristics of malignant pleural mesothelioma in women","volume":"90","author":"Wolf","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2014.04.040","article-title":"Women with malignant pleural mesothelioma have a threefold better survival rate than men","volume":"98","author":"Taioli","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5301\/JBM.2011.8614","article-title":"Biomarkers in malignant mesothelioma: diagnostic and prognostic role of soluble mesothelin-related peptide","volume":"26","author":"Dipalma","year":"2011","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.jtho.2023.08.005_bib30","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/bjc.2017.22","article-title":"Prognostication and monitoring of mesothelioma using biomarkers: a systematic review","volume":"116","author":"Arnold","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2023.08.005_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3892\/ol.2020.12389","article-title":"Potential role of serum mesothelin in predicting survival of patients with malignant pleural mesothelioma","volume":"21","author":"Fontana","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2023.08.005_bib32","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jtho.2023.08.005_bib33","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/JTO.0000000000000661","article-title":"A\u00a0new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma: a review of 12 Years' experience","volume":"10","author":"Opitz","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.athoracsur.2016.06.069","article-title":"A\u00a0Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma","volume":"102","author":"Rusch","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezac085","article-title":"Prospective validation and extension of the Multimodality Prognostic Score for the treatment allocation of pleural mesothelioma patients","volume":"62","author":"Greb","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2023.08.005_bib36","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jtho.2021.06.014","article-title":"Mesothelioma Risk Score: a new prognostic pretreatment, clinical-molecular algorithm for malignant pleural mesothelioma","volume":"16","author":"Yeap","year":"2021","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/jnci\/djp061","article-title":"Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma","volume":"101","author":"Gordon","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtho.2023.08.005_bib38","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41416-022-01950-z","article-title":"A\u00a0combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma","volume":"127","author":"Nguyen","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2023.08.005_bib39","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jtho.2022.03.014","article-title":"Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations","volume":"17","author":"Carbone","year":"2022","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib40","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtho.2023.08.005_bib41","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1073\/pnas.1821510116","article-title":"Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy","volume":"116","author":"Hassan","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.jtho.2023.08.005_bib42","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer discov"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086423007256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086423007256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T05:25:09Z","timestamp":1733030709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086423007256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1556086423007256"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2023.08.005","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}]}}